Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-02-18 Sale | 2025-02-18 9:33 pm | JOHNSON & JOHNSON | JNJ | Schmid Timothy EVP, WW Chair, MedTech | 403 | $156.15 | $62,928 | 17,653 (Direct) | View |
| 2025-02-07 Sale | 2025-02-11 7:40 pm | JOHNSON & JOHNSON | JNJ | Wolk Joseph J Exec VP, CFO | 13,015 | $153.89 | $2,002,878 | 70,948 (Indirect Direct) | View |
| 2024-12-12 Purchase | 2024-12-12 5:27 pm | JOHNSON & JOHNSON | JNJ | WEINBERGER MARK A Director | 1,000 | $147.22 | $147,220 | 1,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-02-15 Option Award | 2025-02-19 5:44 pm | N/A 2035-02-15 | JOHNSON & JOHNSON | JNJ | Wolk Joseph J Exec VP, CFO | 96,909 | $0 | 96,909 (Direct) | View |
| 2025-02-15 Option Award | 2025-02-19 5:37 pm | N/A 2035-02-15 | JOHNSON & JOHNSON | JNJ | Wengel Kathryn E EVP, Chief TO and Risk Officer | 32,744 | $0 | 32,744 (Direct) | View |
| 2025-02-15 Option Award | 2025-02-19 5:35 pm | N/A 2035-02-15 | JOHNSON & JOHNSON | JNJ | Taubert Jennifer L EVP, WWC. Innovative Medicine | 95,320 | $0 | 95,320 (Direct) | View |
| 2025-02-15 Option Award | 2025-02-19 5:33 pm | N/A 2035-02-15 | JOHNSON & JOHNSON | JNJ | Swanson James D. EVP, CIO | 36,603 | $0 | 36,603 (Direct) | View |
| 2025-02-15 Option Award | 2025-02-19 5:31 pm | N/A 2035-02-15 | JOHNSON & JOHNSON | JNJ | Schmid Timothy EVP, WW Chair, MedTech | 52,955 | $0 | 52,955 (Direct) | View |
| 2025-02-15 Option Award | 2025-02-19 5:29 pm | N/A 2035-02-15 | JOHNSON & JOHNSON | JNJ | REED JOHN C EVP, Innovative Medicine, R&D | 95,320 | $0 | 95,320 (Direct) | View |
| 2025-02-15 Option Award | 2025-02-19 5:27 pm | N/A 2035-02-15 | JOHNSON & JOHNSON | JNJ | Mulholland Kristen EVP, Chief HR Officer | 29,676 | $0 | 29,676 (Direct) | View |
| 2025-02-15 Option Award | 2025-02-19 5:25 pm | N/A 2035-02-15 | JOHNSON & JOHNSON | JNJ | Forminard Elizabeth Executive VP, General Counsel | 54,877 | $0 | 54,877 (Direct) | View |
| 2025-02-15 Option Award | 2025-02-19 5:22 pm | N/A 2035-02-15 | JOHNSON & JOHNSON | JNJ | Decker Robert J VP Corporate Controller | 9,388 | $0 | 9,388 (Direct) | View |
| 2025-02-15 Option Award | 2025-02-19 5:18 pm | N/A 2035-02-15 | JOHNSON & JOHNSON | JNJ | Duato Joaquin CEO and Chairman of the Board | 232,533 | $0 | 232,533 (Direct) | View |
| 2025-02-15 Option Award | 2025-02-19 5:16 pm | N/A 2035-02-15 | JOHNSON & JOHNSON | JNJ | Broadhurst Vanessa EVP, Global Corp Affairs | 27,114 | $0 | 27,114 (Direct) | View |
| 2025-02-14 Tax Withholding | 2025-02-18 9:46 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Schmid Timothy EVP, WW Chair, MedTech | 1,015 | $156.71 | 17,657 (Direct) | View |
| 2025-02-14 Exercise | 2025-02-18 9:46 pm | 2025-02-14 N/A | JOHNSON & JOHNSON | JNJ | Schmid Timothy EVP, WW Chair, MedTech | 2,806 | $0 | 17,657 (Direct) | View |
| 2025-02-14 Tax Withholding | 2025-02-18 9:33 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Schmid Timothy EVP, WW Chair, MedTech | 639 | $156.71 | 17,653 (Direct) | View |
| 2025-02-14 Tax Withholding | 2025-02-18 9:33 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Schmid Timothy EVP, WW Chair, MedTech | 193 | $155.26 | 17,653 (Direct) | View |
| 2025-02-13 Exercise | 2025-02-18 9:33 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Schmid Timothy EVP, WW Chair, MedTech | 3,293 | $0 | 17,653 (Direct) | View |
| 2025-02-14 Tax Withholding | 2025-02-18 9:16 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Wengel Kathryn E EVP, Chief TO and Risk Officer | 2,873 | $156.71 | 96,500 (Direct) | View |
| 2025-02-14 Tax Withholding | 2025-02-18 9:16 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Wengel Kathryn E EVP, Chief TO and Risk Officer | 223 | $155.26 | 96,500 (Direct) | View |
| 2025-02-13 Exercise | 2025-02-18 9:16 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Wengel Kathryn E EVP, Chief TO and Risk Officer | 8,625 | $0 | 96,500 (Direct) | View |
| 2025-02-18 Tax Withholding | 2025-02-18 9:16 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Wengel Kathryn E EVP, Chief TO and Risk Officer | 200 | $156.15 | 96,500 (Direct) | View |
| 2025-02-14 Tax Withholding | 2025-02-18 9:13 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Wolk Joseph J Exec VP, CFO | 7,805 | $156.71 | 90,669 (Direct) | View |
| 2025-02-14 Tax Withholding | 2025-02-18 9:13 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Wolk Joseph J Exec VP, CFO | 507 | $155.26 | 90,669 (Direct) | View |
| 2025-02-13 Exercise | 2025-02-18 9:13 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Wolk Joseph J Exec VP, CFO | 23,080 | $0 | 90,669 (Direct) | View |
| 2025-02-18 Tax Withholding | 2025-02-18 9:13 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Wolk Joseph J Exec VP, CFO | 768 | $156.15 | 90,669 (Direct) | View |
| 2025-02-15 Exercise | 2025-02-18 9:11 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | REED JOHN C EVP, Innovative Medicine, R&D | 1,350 | $0 | 18,240 (Direct) | View |
| 2025-02-18 Tax Withholding | 2025-02-18 9:11 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | REED JOHN C EVP, Innovative Medicine, R&D | 385 | $156.15 | 18,240 (Direct) | View |
| 2025-02-14 Tax Withholding | 2025-02-18 9:08 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Taubert Jennifer L EVP, WWC. Innovative Medicine | 9,259 | $156.71 | 182,503 (Direct) | View |
| 2025-02-14 Tax Withholding | 2025-02-18 9:08 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Taubert Jennifer L EVP, WWC. Innovative Medicine | 410 | $155.26 | 182,503 (Direct) | View |
| 2025-02-13 Exercise | 2025-02-18 9:08 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Taubert Jennifer L EVP, WWC. Innovative Medicine | 22,414 | $0 | 182,503 (Direct) | View |
| 2025-02-18 Tax Withholding | 2025-02-18 9:08 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Taubert Jennifer L EVP, WWC. Innovative Medicine | 651 | $156.15 | 182,503 (Direct) | View |
| 2025-02-14 Tax Withholding | 2025-02-18 9:06 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Swanson James D. EVP, CIO | 1,447 | $156.71 | 20,280 (Direct) | View |
| 2025-02-14 Tax Withholding | 2025-02-18 9:06 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Swanson James D. EVP, CIO | 152 | $155.26 | 20,280 (Direct) | View |
| 2025-02-13 Exercise | 2025-02-18 9:06 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Swanson James D. EVP, CIO | 6,018 | $0 | 20,280 (Direct) | View |
| 2025-02-18 Tax Withholding | 2025-02-18 9:06 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Swanson James D. EVP, CIO | 141 | $156.15 | 20,280 (Direct) | View |
| 2025-02-14 Tax Withholding | 2025-02-18 9:05 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Mulholland Kristen EVP, Chief HR Officer | 747 | $156.71 | 15,366 (Direct) | View |
| 2025-02-14 Tax Withholding | 2025-02-18 9:05 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Mulholland Kristen EVP, Chief HR Officer | 141 | $155.26 | 15,366 (Direct) | View |
| 2025-02-13 Exercise | 2025-02-18 9:05 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Mulholland Kristen EVP, Chief HR Officer | 3,438 | $0 | 15,366 (Direct) | View |
| 2025-02-18 Tax Withholding | 2025-02-18 9:05 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Mulholland Kristen EVP, Chief HR Officer | 120 | $156.15 | 15,366 (Direct) | View |
| 2025-02-14 Tax Withholding | 2025-02-18 9:03 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Forminard Elizabeth Executive VP, General Counsel | 731 | $156.71 | 13,475 (Direct) | View |
| 2025-02-14 Tax Withholding | 2025-02-18 9:03 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Forminard Elizabeth Executive VP, General Counsel | 215 | $155.26 | 13,475 (Direct) | View |
| 2025-02-13 Exercise | 2025-02-18 9:03 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Forminard Elizabeth Executive VP, General Counsel | 3,815 | $0 | 13,475 (Direct) | View |
| 2025-02-18 Tax Withholding | 2025-02-18 9:03 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Forminard Elizabeth Executive VP, General Counsel | 307 | $156.15 | 13,475 (Direct) | View |
| 2025-02-14 Tax Withholding | 2025-02-18 9:02 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Duato Joaquin CEO and Chairman of the Board | 10,584 | $156.71 | 418,598 (Direct) | View |
| 2025-02-14 Tax Withholding | 2025-02-18 9:02 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Duato Joaquin CEO and Chairman of the Board | 1,510 | $155.26 | 418,598 (Direct) | View |
| 2025-02-13 Exercise | 2025-02-18 9:02 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Duato Joaquin CEO and Chairman of the Board | 31,487 | $0 | 418,598 (Direct) | View |
| 2025-02-18 Tax Withholding | 2025-02-18 9:02 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Duato Joaquin CEO and Chairman of the Board | 1,602 | $156.15 | 418,598 (Direct) | View |
| 2025-02-14 Tax Withholding | 2025-02-18 9:01 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Decker Robert J VP Corporate Controller | 626 | $156.71 | 22,744 (Direct) | View |
| 2025-02-14 Tax Withholding | 2025-02-18 9:01 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Decker Robert J VP Corporate Controller | 104 | $155.26 | 22,744 (Direct) | View |
| 2025-02-13 Exercise | 2025-02-18 9:01 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Decker Robert J VP Corporate Controller | 2,852 | $0 | 22,744 (Direct) | View |
| 2025-02-18 Tax Withholding | 2025-02-18 9:01 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Decker Robert J VP Corporate Controller | 94 | $156.15 | 22,744 (Direct) | View |
| 2025-02-14 Tax Withholding | 2025-02-18 8:58 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Broadhurst Vanessa EVP, Global Corp Affairs | 1,571 | $156.71 | 24,985 (Direct) | View |
| 2025-02-14 Tax Withholding | 2025-02-18 8:58 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Broadhurst Vanessa EVP, Global Corp Affairs | 151 | $155.26 | 24,985 (Direct) | View |
| 2025-02-13 Exercise | 2025-02-18 8:58 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Broadhurst Vanessa EVP, Global Corp Affairs | 5,640 | $0 | 24,985 (Direct) | View |
| 2025-02-18 Tax Withholding | 2025-02-18 8:58 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Broadhurst Vanessa EVP, Global Corp Affairs | 158 | $156.15 | 24,985 (Direct) | View |
| 2025-02-10 Option Award | 2025-02-12 6:38 pm | 2025-02-14 N/A | JOHNSON & JOHNSON | JNJ | Decker Robert J VP Corporate Controller | 1,351 | $0 | 1,351 (Direct) | View |
| 2025-02-10 Option Award | 2025-02-12 6:37 pm | 2025-02-14 N/A | JOHNSON & JOHNSON | JNJ | Forminard Elizabeth Executive VP, General Counsel | 1,352 | $0 | 1,352 (Direct) | View |
| 2025-02-10 Option Award | 2025-02-12 6:35 pm | 2025-02-14 N/A | JOHNSON & JOHNSON | JNJ | Wolk Joseph J Exec VP, CFO | 15,316 | $0 | 15,316 (Direct) | View |
| 2025-02-10 Option Award | 2025-02-12 6:32 pm | 2025-02-14 N/A | JOHNSON & JOHNSON | JNJ | Wengel Kathryn E EVP, Chief TO and Risk Officer | 5,837 | $0 | 5,837 (Direct) | View |
| 2025-02-10 Option Award | 2025-02-12 6:21 pm | 2025-02-14 N/A | JOHNSON & JOHNSON | JNJ | Mulholland Kristen EVP, Chief HR Officer | 1,601 | $0 | 1,601 (Direct) | View |
| 2025-02-10 Option Award | 2025-02-12 6:18 pm | 2025-02-14 N/A | JOHNSON & JOHNSON | JNJ | Taubert Jennifer L EVP, WWC. Innovative Medicine | 15,465 | $0 | 15,465 (Direct) | View |
| 2025-02-10 Option Award | 2025-02-12 6:10 pm | 2025-02-14 N/A | JOHNSON & JOHNSON | JNJ | Schmid Timothy EVP, WW Chair, MedTech | 2,806 | $0 | 2,806 (Direct) | View |
| 2025-02-10 Option Award | 2025-02-12 6:07 pm | 2025-02-14 N/A | JOHNSON & JOHNSON | JNJ | Swanson James D. EVP, CIO | 3,118 | $0 | 3,118 (Direct) | View |
| 2025-02-10 Option Award | 2025-02-12 5:53 pm | 2025-02-14 N/A | JOHNSON & JOHNSON | JNJ | Duato Joaquin CEO and Chairman of the Board | 19,282 | $0 | 19,282 (Direct) | View |
| 2025-02-10 Option Award | 2025-02-12 5:38 pm | 2025-02-14 N/A | JOHNSON & JOHNSON | JNJ | Broadhurst Vanessa EVP, Global Corp Affairs | 2,910 | $0 | 2,910 (Direct) | View |
| 2025-02-07 Tax Withholding | 2025-02-11 7:43 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Duato Joaquin CEO and Chairman of the Board | 100,643 | $153.12 | 389,974 (Direct) | View |
| 2025-02-07 Exercise | 2025-02-11 7:43 pm | 2018-02-10 2025-02-09 | JOHNSON & JOHNSON | JNJ | Duato Joaquin CEO and Chairman of the Board | 126,369 | $100.06 | 389,974 (Direct) | View |
| 2025-02-07 Tax Withholding | 2025-02-11 7:42 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Wengel Kathryn E EVP, Chief TO and Risk Officer | 26,076 | $153.12 | 89,308 (Direct) | View |
| 2025-02-07 Exercise | 2025-02-11 7:42 pm | 2018-02-10 2025-02-09 | JOHNSON & JOHNSON | JNJ | Wengel Kathryn E EVP, Chief TO and Risk Officer | 32,762 | $100.06 | 89,308 (Direct) | View |
| 2025-02-07 Tax Withholding | 2025-02-11 7:41 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Taubert Jennifer L EVP, WWC. Innovative Medicine | 47,436 | $153.12 | 165,919 (Direct) | View |
| 2025-02-07 Exercise | 2025-02-11 7:41 pm | 2018-02-10 2025-02-09 | JOHNSON & JOHNSON | JNJ | Taubert Jennifer L EVP, WWC. Innovative Medicine | 58,504 | $100.06 | 165,919 (Direct) | View |
| 2025-02-07 Exercise | 2025-02-11 7:40 pm | 2018-02-10 2025-02-09 | JOHNSON & JOHNSON | JNJ | Wolk Joseph J Exec VP, CFO | 13,015 | $100.06 | 70,948 (Direct) | View |
| 2024-12-10 Option Award | 2024-12-12 5:16 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Woods Eugene A. Director | 209 | $149.67 | 2,805 (Direct) | View |
| 2024-12-10 Option Award | 2024-12-12 5:09 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | HEWSON MARILLYN A Director | 335 | $149.67 | 11,380 (Direct) | View |